English (UK)
English (US)Sydney, 19 August 2025 – UnderwriteMe is proud to announce its role in powering an industry-first innovation with Acenda, delivering Australia’s first fully digital life insurance underwriting process involving Personal Medical Attendant Reports (PMARs).
This breakthrough allows doctors’ reports and medical exam findings to flow directly into Acenda’s underwriting engine via UnderwriteMe’s technology, enabling faster decisions, greater efficiency, and a better experience for customers and advisers.
The collection and assessment of medical evidence has been one of the most time-consuming stages of life insurance underwriting. By combining UnderwriteMe’s advanced underwriting and automated data sourcing capabilities with Acenda’s award-winning collaboration with EQ Pathology, the process is now fully digitised from evidence collection to automated decisioning, removing the need for traditional paper-based workflows.
Jane Murray, Chief Operating Officer at Acenda said, “Our partnership with UnderwriteMe transforms the way medical information is collected and processed. By fully digitising the underwriting process, we can offer an unprecedented level of speed and efficiency for advisers and customers alike.”
This launch marks a significant milestone in UnderwriteMe’s mission to make insurance more accessible. By enabling insurers to automate complex underwriting journeys, integrate seamlessly with multiple data sources, and deliver a better experience for customers and advisers, UnderwriteMe continues to set new benchmarks for innovation and delivers meaningful change across the industry.
Paul Hughes, Chief Revenue and Customer Officer at UnderwriteMe added, “We have been proud supporters of Acenda for several years in the Australian market, and this latest innovation is a game changer. By leveraging technology to solve critical challenges in secondary evidence underwriting, Acenda are making it easier for Australians to obtain their cover in a swifter and smoother way. We are delighted to have collaborated with Acenda and EQ Pathology in delivering this exciting industry-first innovation.”
Read more about the partnership between Acenda, EQ Pathology and UnderwriteMe on Financial Newswire or IFA Australia.